But_home
But_blogshome
But_forum
Icon_rss_infobarSubscribe to receive updates
on new articles and posts from this blog.
 

Can the "heart team" work?

Btn-download-en

Despite increased communication between cardiologists and cardiac surgeons, the two parties--much like our political representatives--seem locked to opposing views and unable to find common ground.

Can cardiologists commit to the heart team? Can they take more time between diagnostic catheterization and PCI intervention in patients with complex multivessel disease?

Can surgeons be receptive to PCI in cases where evidence suggests it is appropriate?

Comments

Dr. Gardner continues to make excellent and insightful comments.  He discusses the topic which is unfortunately the foundation for the ‘battle’ between interventional cardiologists and cardiac surgeons.  CABG vs. PCI continues to cause significant disagreement between these two specialties.  While I believe we all have our patients needs at ‘heart’ I think this issue has become more of a political and financial battle.  As Dr. Gardner points out it is very similar to what we have seen in Congress with either side refusing to even consider the other side’s point of view.  The reality is that there are compelling arguments for both sides and at the end of the day this needs to be a patient specific decision.  This is of course best done by a multidisciplinary heart team that should include a non-interventional (ideally the patients own) cardiologist.  In all patients we need to consider medical, interventional, surgical or hybrid (my favorite) options to treat their coronary disease.  It is important when these groups meet that the foundation is that of ideal treatment of the patient.  While there will be contentious topics this should not be viewed as a battle ground.  We have seen this approach applied successfully in the groups with valve clinics deciding TAVR vs AVR and this should serve as the model.  Unfortunately we have also seen the PCI v. CABG issue arise in terms of transapical (or transaortic) vs transfemoral TAVR.  I hope that going forward in all areas focused on treating cardiovascular disease that we avoid the ingrained approach of ‘us vs. them’ and create teams focused exclusively on the patient.  I personally believe this will best be done by aligning incentives among the practitioners so we are all truly one team.


Posted by Mathew Williams, Dec 30, 2011 at 08:29 AM, EDT

Add your own comments



 


This blog on theheart.org is a sounding board for healthcare providers, clinicians, and researchers, and is not intended to supply answers or advice to patients. We reserve the right to remove posts containing inappropriate language, promotional content, personal agendas or hostile intent, and posts from patients asking for medical advice.

In the interest of promoting a balanced exchange, please disclose any relevant relationships or conflicts of interest when posting your comment.

The views and opinions expressed herein are those of the blogger and do not necessarily reflect those of theheart.org.


About Tim Gardner MD
Timothy Gardner, a senior heart surgeon and leader in cardiovascular medicine, is medical director of Christiana Care's Center for Heart & Vascular Health and clinical professor of surgery at the University of Pennsylvania.

Dr Gardner is past president of both the American Heart Association and the American Association for Thoracic Surgery and former chair of the American Board of Thoracic Surgery. Prior to his current position at Christiana Care, he was chief of cardiothoracic surgery at the University of Pennsylvania.

Dr Gardner has no relevant financial relationships.
About Mat Williams MD
Mathew Williams is assistant professor of surgery and medicine at Columbia University College of Physicians and Surgeons. Dr Williams is also surgical director of Cardiovascular Transcatheter Therapies and associate director of the Cardiothoracic Fellowship at New York-Presbyterian Hospital/Columbia University Medical Center, where he is attending surgeon and interventional cardiologist.

Dr Williams has served as an advisor or consultant for Edwards Lifesciences, Medtronic, and St Jude Medical.
About this blog
The aims of this exchange are to offer insight into the ever-evolving world of cardiovascular surgery and provide a forum for debate for surgeons, interventional cardiologists, and the wider cardiovascular community. Join Drs Gardner and Williams for their thoughts on practice, research, news, and events from the cutting edge.